Meanwhile, IL-10, a potent immunosuppressive cytokine, supports tumor progression by enhancing myeloma cell survival, dampening anti-tumor immune responses, and promoting resistance to therapy [120]. The gene discussed is IL10; the disease is plasma cell myeloma.